Detalhe da pesquisa
1.
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial.
Eur Heart J
; 43(41): 4362-4373, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35900838
2.
Effects of Serelaxin in Patients with Acute Heart Failure.
N Engl J Med
; 381(8): 716-726, 2019 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31433919
3.
Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial.
Am Heart J
; 190: 113-122, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28760204
4.
Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial.
Eur J Heart Fail
; 24(1): 230-238, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34800079
5.
Baseline characteristics of patients in the PARALLAX trial: insights into quality of life and exercise capacity in heart failure with preserved ejection fraction.
Eur J Heart Fail
; 23(9): 1541-1551, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34170062
6.
Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial.
ESC Heart Fail
; 7(3): 856-864, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32297449
7.
[Chest pain unit--viable option when risk of cardiac etiology is modest. Multitudinous patient population brought together for structured survey and care at appropriate level]. / Bröstsmärtsenhet--bra alternativ vid låg risk för kardiell genes. Spridd patientgrupp samlas för strukturerad utredning och vård på rätt nivå.
Lakartidningen
; 99(48): 4848-53, 2002 Nov 28.
Artigo
em Sueco
| MEDLINE | ID: mdl-12523070